Protective effects of Eleutheroside E against high-altitude pulmonary edema by inhibiting NLRP3 inflammasome-mediated pyroptosis

Zherui Shen,Demei Huang,Nan Jia,Sijing Zhao,Caixia Pei,Yilan Wang,Yongcan Wu,Xiaomin Wang,Shihua Shi,Fei Wang,Yacong He,Zhenxing Wang
DOI: https://doi.org/10.1016/j.biopha.2023.115607
IF: 7.419
2023-10-01
Biomedicine & Pharmacotherapy
Abstract:Eleutheroside E (EE) is a primary active component of Acanthopanax senticosus , which has been reported to inhibit the expression of inflammatory genes, but the underlying mechanisms remain elusive. High-altitude pulmonary edema (HAPE) is a severe complication of high-altitude exposure occurring after ascent above 2500 m. However, effective and safe preventative measures for HAPE still need to be improved. This study aimed to elucidate the preventative potential and underlying mechanism of EE in HAPE. Rat models of HAPE were established through hypobaric hypoxia. Mechanistically, hypobaric hypoxia aggravates oxidative stress and upregulates (pro)-inflammatory cytokines, activating NOD-like receptor protein 3 (NLRP3) inflammasome-mediated pyroptosis, eventually leading to HAPE. EE suppressed NLRP3 inflammasome-mediated pyroptosis by inhibiting the nuclear translocation of nuclear factor kappa-Β (NF-κB), thereby protecting the lung from HAPE. However, nigericin (Nig), an NLRP3 activator, partially abolished the protective effects of EE. These findings suggest EE is a promising agent for preventing HAPE induced by NLRP3 inflammasome-mediated pyroptosis.
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?